Crystal structure of monoclonal anti-human podoplanin antibody NZ-1
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| C | | e4ynyC1 | A: HTH | X: SH3 | H: SH3 | T: LRR_1+LRR_8+LRR_14 | F: | ECOD (20:10:01) |
| A | | e4ynyA1 | A: HTH | X: SH3 | H: SH3 | T: LRR_1+LRR_8+LRR_14 | F: | ECOD (20:10:01) |
| D | | e4ynyD1 | A: HTH | X: SH3 | H: SH3 | T: LRR_1+LRR_8+LRR_14 | F: | ECOD (20:10:01) |
| B | | e4ynyB1 | A: HTH | X: SH3 | H: SH3 | T: LRR_1+LRR_8+LRR_14 | F: | ECOD (20:10:01) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | NZ-1 Fab, anti-human podoplanin | VH-CH1 | Rattus norvegicus (Norway rat) | IGHV5S14*01, IGHJ2*01, IGHG2A*01 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-2A_LAMBDA | IMGT (202609-0) |
| | NZ-1 Fab, anti-human podoplanin | L-LAMBDA | Rattus norvegicus (Norway rat) | IGLV3S2*01, IGLJ3*01, IGLJ1*01, IGLC1*01, IGLC3*01 | V-DOMAIN V-LAMBDA, C-DOMAIN C-LAMBDA | IG | FAB-GAMMA-2A_LAMBDA | IMGT (202609-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Heavy Chain | IGHV5 | - | - | SAbDab (2026-03-13) |
| | Light Chain | IGLV3 | Lambda | - | SAbDab (2026-03-13) |
Protein Modification Annotation
| Modified Residue(s) |
|---|
| Chain | Residue(s) | Description |
|---|
| | PCA | Parent Component: GLN
RESID:  AA0031
PSI-MOD :  2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 |